GNC Holdings, Inc. engages in the global retail of health, wellness and performance products, including vitamins, minerals and herbal supplements products, sports nutrition products and diet products. It operates through the following segments: U.S. & Canada, International and Manufacturing or Wholesale. The U.S. and Canada segment generates revenues primarily from sales of products to customers. The International segment generates revenue primarily from its international franchisees through product sales, royalties and franchise fees and also includes its China operations and The Health Store. The Manufacturing or Wholesale segment comprises of its manufacturing operations in South Carolina and its wholesale partner relationships. The company was founded by David Shakarian in 1935 and is headquartered in Pittsburgh, PA.
Company profile
Ticker
GNCIQ
Website
CEO
Kenneth A. Martindale
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
GNC ACQUISITION HOLDINGS INC.
SEC CIK
Corporate docs
Subsidiaries
GNC Parent LLC • GNC Corporation • General Nutrition Centers, Inc. • GNC Funding, Inc. • General Nutrition Corporation • General Nutrition Investment Company • GNC Puerto Rico, LLC • General Nutrition Centres Company • GNC Columbia SAS • Lucky Oldco Corporation ...
IRS number
208536244
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
7 Oct 20
15-12B
Securities registration termination
7 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Oct 20
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Oct 20
8-K
Entry into a Material Definitive Agreement
23 Sep 20
8-K
Regulation FD Disclosure
14 Sep 20
8-K
Entry into a Material Definitive Agreement
21 Aug 20
10-Q
2020 Q2
Quarterly report
10 Aug 20
Latest ownership filings
SC 13G/A
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
16 Feb 21
4
Kenneth Martindale
15 Sep 20
SC 13D/A
Harbin Pharmaceutical Group Co., Ltd.
10 Aug 20
SC 13G/A
BlackRock Inc.
10 Jul 20
SC 13G/A
Tang PC
29 Jun 20
SC 13D/A
Harbin Pharmaceutical Group Co., Ltd.
24 Jun 20
4
Michele S. Meyer
21 May 20
4
Hsing Chow
21 May 20
4
PHILIP E MALLOTT
21 May 20
4
ALAN D FELDMAN
21 May 20
Financial summary
Quarter (USD) | Jun 20 | Mar 20 | Sep 19 | Jun 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 96.43 mm | 96.43 mm | 96.43 mm | 96.43 mm | 96.43 mm | 96.43 mm |
Cash burn (monthly) | 13.67 mm | 3.39 mm | 32.00 mm | 19.51 mm | (no burn) | (no burn) |
Cash used (since last report) | 624.48 mm | 154.88 mm | 1.46 bn | 891.10 mm | n/a | n/a |
Cash remaining | -528.06 mm | -58.45 mm | -1.37 bn | -794.68 mm | n/a | n/a |
Runway (months of cash) | -38.6 | -17.2 | -42.7 | -40.7 | n/a | n/a |